Acutaas Chemicals reported FY26 revenue of ₹13,394 million and net profit of ₹3,564 million, showing significant growth from previous years.
The company disclosed ₹1,000+ crore capex pipeline from FY23-FY30 across pharma, battery, semiconductor segments and a new R&D center.
Strategic expansions include entry into battery additives and semiconductors via JV Indichem Inc. in South Korea, alongside major capacity increases.
Corporate rebranding from Ami Organics to Acutaas Chemicals reflects sharper focus on specialty and custom chemical solutions across global markets.